INmune Bio Inc. Common stock
Symbol: INMB (NASDAQ)
1.77
▼ (-0.84%) -0.015
Company Description:
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Key Stats
- Today's Open: $1.71
- Today's High: $1.83
- Today's Low: $1.685
- Today's Volume: 580.24K
- Yesterday Close: $1.78
- Yesterday High: $1.83
- Yesterday Low: $1.7294
- Yesterday Volume: 952.05K
- Last Min Volume: 8
- Last Min High: $1.765
- Last Min Low: $1.765
- Last Min VWAP: $1.765
Company Profile
- Name: INmune Bio Inc. Common stock
- Website: https://www.inmunebio.com
- Listed Date: 2019-02-04
- Location: BOCA RATON, FL
- Market Status: Active
- CIK Number: 0001711754
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $48.12M
- Round Lot: 100
- Outstanding Shares: 26.59M
- Asset Type: CS
RECENT FILINGS FOR INMB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | 3 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-07-29 | 8-K | View |
| 2025-07-25 | 8-K | View |
| 2025-07-02 | SCHEDULE 13G | View |
| 2025-06-30 | 8-K | View |
| 2025-06-30 | 424B5 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-06-16 | S-8 | View |
| 2025-06-16 | S-8 | View |
| 2025-06-10 | 8-K | View |
| 2025-05-14 | 8-K | View |
| 2025-05-09 | DEFR14A | View |
| 2025-05-08 | 8-K | View |
| 2025-05-08 | 10-Q | View |
Latest News on INMB